Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alnylam Pharmaceuticals Inc. May 18, 202389.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 23, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +11,250 | $131.21 | $1,476,113 |
| Jan 23, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −11,250 | $275.00 | $3,093,750 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Option exercise | +30,000 | $59.25 | $1,777,500 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −13,005 | $150.60 | $1,958,553 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −13,557 | $151.43 | $2,052,937 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −915 | $152.40 | $139,446 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,906 | $153.62 | $292,800 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −101 | $154.07 | $15,561 |
| Feb 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −516 | $156.54 | $80,775 |
| May 22, 2023 | Vir Biotechnology Inc. | Grant or award | +6,027 | — | — |
Questions about Phillip A. Sharp
What boards is Phillip A. Sharp on?
Phillip A. Sharp sits on the boards of Alnylam Pharmaceuticals Inc. and Vir Biotechnology Inc.
How long has Phillip A. Sharp served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.